More recent studies have identified that a majority of prostate tumors harbor prostate-specific TMPRSS2 gene and the ERG oncogene (TMPRSS2: ERG) gene fusion which could be used as a stem cell marker with high specificity providing ERG-driven survival advantages[67]. Here, TMPRSS2 is linked to prostate neoplasm.